SCHEMBL24944389

SCHEMBL24944389

COc1nc(Nc2ccc(N3CCOCC3)cc2)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ ALK Q9UM73 5/20 0.43
▸ EML4 Q9HC35 4/20 0.43
▸ CCNA2 P20248 2/20 0.43
▸ CDK2 P24941 2/20 0.43
▸ AURKA O14965 1/20 0.43
▸ CDK4 P11802 1/20 0.43
▸ CCND3 P30281 1/20 0.43
▸ CDK6 Q00534 1/20 0.43
▸ STAT6 P42226 2/20 0.42
▸ CSF1R P07333 2/20 0.42
▸ SYK P43405 3/20 0.41
▸ RET P07949 2/20 0.41
▸ ROS1 P08922 2/20 0.41
▸ FLT3 P36888 2/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ PKMYT1 Q99640 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ NTRK1 P04629 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205485 1.00 LCK (0.43) LCKJAK3ALKEML4CCNA2
SCHEMBL24943796 0.92 EML4 (0.46) LCKJAK3ALKEML4CCNA2
SCHEMBL30205537 0.92 EML4 (0.46) LCKJAK3ALKEML4CCNA2
SCHEMBL30206126 0.90 EML4 (0.44) LCKJAK3ALKEML4CCNA2
SCHEMBL24944375 0.90 EML4 (0.44) LCKJAK3ALKEML4CCNA2
SCHEMBL24944729 0.90 EML4 (0.45) LCKJAK3ALKEML4CCNA2
SCHEMBL30205764 0.90 EML4 (0.45) LCKJAK3ALKEML4CCNA2
SCHEMBL24944959 0.90 EML4 (0.45) LCKJAK3ALKEML4CCNA2
SCHEMBL30205765 0.90 EML4 (0.45) LCKJAK3ALKEML4CCNA2
SCHEMBL24943791 0.89 EML4 (0.48) LCKJAK3ALKEML4CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN claimed
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback